2025 annual financial data
Telomir Pharmaceuticals 2025 Operating margin
Telomir Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -10,538,849 USD and net income was -10,413,205 USD.
Operating cash flow was -3,688,188 USD.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,538,849 USD
- Net income
- -10,413,205 USD
- Operating cash flow
- -3,688,188 USD